Cytokine and tumor cell apoptosis inducing activity of mda-7/IL-24
Rahul V Gopalkrishnan1, Moira Sauane, Paul B Fisher
1Department of Pathology, College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA. rg285@columbia.edu
Abstract:
Melanoma Differentiation Associated gene-7 (mda-7)/IL-24 has shown potent tumor cell apoptosis inducing capacity in multiple cancers, making it a strong candidate for use as a human cancer gene therapeutic. Several independent studies have currently documented and confirmed mda-7/IL-24's cytokine nature including presence of a canonical secretory signal peptide, processing and secretion of the molecule by cells and it's binding to specific interleukin receptors on the cell surface. Receptor binding has been shown to activate the JAK/STAT signal transduction pathway with concomitant stimulation of STAT 1 and 3 transactivators. The physiological role(s) of this molecule in modulating immune responses, as a member of the IL-10 family of cytokines, is not well documented and most current information pertains to its apparently restricted expression patterns in specific cell types with immunomodulatory activity. On the other hand, several additional signal transduction pathways were modulated when cells overexpress mda-7/IL-24, not all of which are necessarily downstream of mda-7/IL-24 induced JAK/STAT activation. A summary of the current status of information is presented to provide a perspective for the cytokine-related properties of mda-7/IL-24 in correlation to its tumor cell apoptosis inducing activity. Moreover, new evidence has surfaced pointing toward apoptosis induction via mechanisms independent of cytokine activity-related JAK/STAT activation.
Insights
Melanoma Differentiation Associated gene-7 (mda-7)/IL-24, a potent cancer therapeutic, acts as a cytokine that induces tumor cell apoptosis. New evidence suggests it may also trigger apoptosis through mechanisms independent of its known JAK/STAT pathway activation.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- Melanoma Differentiation Associated gene-7 (mda-7)/IL-24 exhibits potent tumor cell apoptosis-inducing capacity, making it a promising cancer gene therapeutic.
- mda-7/IL-24 is confirmed as a cytokine with a secretory signal peptide, processed and secreted by cells, and binds to specific interleukin receptors.
Purpose of the Study:
- To summarize the current understanding of mda-7/IL-24's cytokine properties in relation to its tumor cell apoptosis-inducing activity.
- To explore evidence for apoptosis induction mechanisms independent of JAK/STAT pathway activation.
Main Methods:
- Literature review and synthesis of existing studies on mda-7/IL-24.
- Analysis of signal transduction pathways modulated by mda-7/IL-24 overexpression.
Main Results:
- mda-7/IL-24 binding to receptors activates the JAK/STAT pathway, stimulating STAT 1 and 3.
- Overexpression of mda-7/IL-24 modulates multiple signal transduction pathways, not all downstream of JAK/STAT.
- Emerging evidence indicates apoptosis induction via mechanisms independent of cytokine activity-related JAK/STAT activation.
Conclusions:
- mda-7/IL-24 possesses dual mechanisms for inducing tumor cell apoptosis, involving both cytokine-dependent and independent pathways.
- Further research is needed to fully elucidate the physiological roles of mda-7/IL-24 in immune responses and its non-JAK/STAT-mediated functions.
More Related Videos
11:21Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
Published on: January 26, 2019
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
